TALICIA

This brand name is authorized in United States

Active ingredients

The drug TALICIA contains a combination of these active pharmaceutical ingredients (APIs):

1 Omeprazole
UNII 426QFE7XLK - OMEPRAZOLE MAGNESIUM

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

Read about Omeprazole
2 Amoxicillin
UNII 804826J2HU - AMOXICILLIN

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

Read about Amoxicillin
3 Rifabutin
UNII 1W306TDA6S - RIFABUTIN

Rifabutin is an antibiotic used to treat tuberculosis and prevent and treat Mycobacterium avium complex.

Read about Rifabutin

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 57841-1150

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.